Penicillin in Borrelia burgdorferi-negative Primary Cutaneous Marginal Zone Lymphoma: A Case Series and Literature Review
DOI:
https://doi.org/10.2340/actadv.v102.198Abstract
Abstract is missing (Short communication)
Downloads
References
Hristov AC, Tejasvi T, Wilcox RA. Cutaneous B-cell lymphomas: 2021 update on diagnosis, risk-stratification, and management. Am J Hematol 2020; 95: 1209-1213.
https://doi.org/10.1002/ajh.25970
Ponzoni M, Ferreri AJM, Mappa S, Pasini E, Govi S, Facchetti F, et al. Prevalence of Borrelia burgdorferi infection in a series of 98 primary cutaneous lymphomas. Oncologist 2011; 16: 1582-1588.
https://doi.org/10.1634/theoncologist.2011-0108
Monari P, Farisoglio C, Calzavara Pinton PG. Borrelia burgdorferi-associated primary cutaneous marginal-zone B-cell lymphoma: a case report. Dermatology 2007; 215: 229-232.
https://doi.org/10.1159/000106580
Yildirim FE, Karaduman A, Hürmüz P, Ozyar E, Barişta I, Sağlam A. Symmetrical primary cutaneous marginal zone lymphoma associated with rheumatoid arthritis. J Cutan Pathol 2010; 37: 600-604.
https://doi.org/10.1111/j.1600-0560.2009.01393.x
Ghatalia P, Porter J, Wroblewski D, Carlson JA. Primary cutaneous marginal zone lymphoma associated with juxta-articular fibrotic nodules in a teenager. J Cutan Pathol 2013; 40: 477-484.
https://doi.org/10.1111/cup.12102
Bonin S, Stinco G, Patriarca MM, Trevisini S, di Meo N, Trevisan G. Could co-infection with anaplasma play a role in Borrelia-associated primary cutaneous marginal zone B-cell lymphomas? Indian J Dermatol Venereol Leprol 2016; 82: 81-84.
https://doi.org/10.4103/0378-6323.171011
Jothishankar B, Di Raimondo C, Mueller L, Zain J, Parekh V, Abdulla F. Primary cutaneous marginal zone lymphoma treated with doxycycline in a pediatric patient. Pediatr Dermatol 2020; 37: 759-761.
https://doi.org/10.1111/pde.14165
Golling P, Cozzio A, Dummer R, French L, Kempf W. Primary cutaneous B-cell lymphomas - clinicopathological, prognostic and therapeutic characterisation of 54 cases according to the WHO-EORTC classification and the ISCL/EORTC TNM classification system for primary cutaneous lymphomas other than mycosis fungoides and Sezary syndrome. Leuk Lymphoma 2008; 49: 1094-1103.
https://doi.org/10.1080/10428190802064925
Pirahmadi N, Zarghi A, Salimi A, Arefi H, Pourahmad J. β-lactam Structured, 4-(4-(Methylsulfonyl)phenyl)-1-pentyl-3-phenoxyazetidin-2-one: Selectively Targets Cancerous B Lymphocyte Mitochondria. Anticancer Agents Med Chem 2017; 17: 1292-1301.
https://doi.org/10.2174/1871520617666170213144113
Kuhlmann I. The prophylactic use of antibiotics in cell culture. Cytotechnology 1995; 19: 95-105.
https://doi.org/10.1007/BF00749764
Neftel KA, Müller MR, Widmer U, Hügin AW. Beta-lactam antibiotics inhibit human in vitro granulopoiesis and proliferation of some other cell types. Cell Biol Toxicol 1986; 2: 513-521.
https://doi.org/10.1007/BF00117853
Lim M, Bradshaw S, Kirchhof MG. Primary cutaneous low-grade B-cell lymphoma treated with hydroxychloroquine. JAAD Case Rep 2020; 6: 1048-1050.
Additional Files
Published
How to Cite
License
Copyright (c) 2022 Yang Wang, Yao Qin
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (https://creativecommons.org/licenses/by-nc/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material for non-commercial purposes, provided proper attribution to the original work.
